We are live on ! Find out more
CG

Cutler Group Portfolio holdings

AUM $307M
1-Year Est. Return 45.11%
This Fund
S&P 500
This Quarter Est. Return
+7.53%
1 Year Est. Return
+45.11%
3 Year Est. Return
+57.72%
5 Year Est. Return
+302.49%
10 Year Est. Return
AUM
$2.71B
AUM Growth
+$307M
Cap. Flow
+$2.8B
Cap. Flow %
103.22%
Top 10 Hldgs %
23.01%
Holding
7,805
New
1,401
Increased
2,380
Reduced
2,248
Closed
1,408

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 10.94%
2 Technology 10.44%
3 Healthcare 6.66%
4 Communication Services 6.39%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
2526
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$49K ﹤0.01%
21,400
-123,200
-85% -$1.53M
CVRR
2527
CALL
DELISTED
CVR Refining, LP
CVRR
$49K ﹤0.01%
98,500
+51,900
+111% +$499K
QCP
2528
DELISTED
Quality Care Properties, Inc.
QCP
$49K ﹤0.01%
2,688
+2,568
+2,140% +$46.2K
CEMP
2529
DELISTED
Cempra, Inc.
CEMP
$49K ﹤0.01%
10,786
-18,563
-63% -$73.3K
VSTO
2530
CALL
DELISTED
Vista Outdoor Inc.
VSTO
$49K ﹤0.01%
33,100
+27,400
+481% +$578K
AM
2531
DELISTED
ANTERO MIDSTREAM PARTNERS LP
AM
$49K ﹤0.01%
+1,492
New +$49.7K
AMAT icon
2532
PUT
Applied Materials
AMAT
$347B
$48K ﹤0.01%
+31,600
New +$1.34M
APH icon
2533
Amphenol
APH
$185B
$48K ﹤0.01%
+2,608
New +$47.6K
CLDT
2534
Chatham Lodging
CLDT
$632M
$48K ﹤0.01%
2,400
-200
-8% -$3.94K
COP icon
2535
PUT
ConocoPhillips
COP
$144B
$48K ﹤0.01%
49,600
-19,100
-28% -$891K
CYTK icon
2536
Cytokinetics
CYTK
$10.6B
$48K ﹤0.01%
4,018
-11,434
-74% -$159K
DXCM icon
2537
CALL
DexCom
DXCM
$29B
$48K ﹤0.01%
129,600
+43,200
+50% +$798K
IBM icon
2538
CALL
IBM
IBM
$213B
$48K ﹤0.01%
30,648
+1,988
+7% +$300K
IBM icon
2539
PUT
IBM
IBM
$213B
$48K ﹤0.01%
18,200
-104,391
-85% -$15.7M
INO icon
2540
Inovio Pharmaceuticals
INO
$85.6M
$48K ﹤0.01%
+518
New +$44.3K
LUMN icon
2541
CALL
Lumen
LUMN
$6.43B
$48K ﹤0.01%
136,000
+107,100
+371% +$2.69M
MDLZ icon
2542
PUT
Mondelez International
MDLZ
$83.4B
$48K ﹤0.01%
105,100
-5,500
-5% -$248K
MOH icon
2543
PUT
Molina Healthcare
MOH
$10.4B
$48K ﹤0.01%
7,800
+5,500
+239% +$337K
QRVO icon
2544
CALL
Qorvo
QRVO
$7.9B
$48K ﹤0.01%
12,700
-2,800
-18% -$200K
SNCR
2545
PUT
DELISTED
Synchronoss Technologies
SNCR
$48K ﹤0.01%
7,600
+7,400
+3,700% +$1.1M
TRGP icon
2546
PUT
Targa Resources
TRGP
$56.8B
$48K ﹤0.01%
28,300
-24,700
-47% -$1.24M
UHT
2547
Universal Health Realty Income Trust
UHT
$621M
$48K ﹤0.01%
612
-1,000
-62% -$72.1K
W icon
2548
PUT
Wayfair
W
$11.8B
$48K ﹤0.01%
19,000
+16,400
+631% +$972K
YINN icon
2549
Direxion Daily FTSE China Bull 3X ETF
YINN
$758M
$48K ﹤0.01%
110
+27
+33% +$11.4K
BKCC
2550
DELISTED
BlackRock Capital Investment Corporation
BKCC
$48K ﹤0.01%
6,536
+230
+4% +$1.72K

Similar funds

Cutler Group's Q2 2017 Portfolio in Review

As of Q2 2017, Cutler Group held 7,805 positions worth $2.71B, up 13% from $2.4B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Cutler Group deployed $2.8B of net new capital in Q2 2017, opening 1,401 new positions and adding to 2,380 existing holdings. Its largest new stake was iShares US Medical Devices ETF: 316,230 shares worth $8.78M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 11% of assets, up from 6.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $77.9M trimmed.

  • Cutler Group's largest Q2 2017 buy was iShares US Medical Devices ETF: 316,230 shares worth $8.78M.
  • Cutler Group added most to Amazon in Q2 2017, an estimated $125M increase.
  • Cutler Group's biggest Q2 2017 reduction was Apple, cutting an estimated $77.9M.
  • Cutler Group fully exited Invesco QQQ Trust in Q2 2017, selling an estimated $79.3M.
  • Cutler Group's ten largest holdings make up 23% of its $2.71B portfolio in Q2 2017.
  • Cutler Group opened 1,401 new positions and closed 1,408 in Q2 2017.
  • Cutler Group's portfolio value rose 13% quarter-over-quarter to $2.71B.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.